# Liquidmetal Technologies Inc: financial statements, quarterly

LQMT · OTC · CIK 1141240 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lqmt.md) · [Financials](/companies/lqmt/financials.md) · [Filings](/companies/lqmt/filings.md) · [Insiders](/companies/lqmt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lqmt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [127](/filings/0001437749-24-032664.md) | [286 d](/filings/0001437749-25-007519.md) | [173](/filings/0001437749-25-016434.md) | [242](/filings/0001437749-25-026496.md) | [316](/filings/0001437749-25-034818.md) | [129 d](/filings/0001437749-26-007965.md) | [282](/filings/0001437749-26-015930.md) | [289](/filings/0001437749-26-026257.md) | [37.0](/filings/0001437749-25-034818.md) | [176 d](/filings/0001437749-26-007965.md) | [256](/filings/0001437749-26-015930.md) | [196](/filings/0001437749-26-026257.md) |
| Cost of revenue | $k | [89.0](/filings/0001437749-24-032664.md) | [197 d](/filings/0001437749-25-007519.md) | [134](/filings/0001437749-25-016434.md) | [187](/filings/0001437749-25-026496.md) | [239](/filings/0001437749-25-034818.md) | [83.0 d](/filings/0001437749-26-007965.md) | [204](/filings/0001437749-26-015930.md) | [212](/filings/0001437749-26-026257.md) | [17.0](/filings/0001437749-25-034818.md) | [121 d](/filings/0001437749-26-007965.md) | [179](/filings/0001437749-26-015930.md) | [107](/filings/0001437749-26-026257.md) |
| Gross profit | $k | [38.0](/filings/0001437749-24-032664.md) | [89.0 d](/filings/0001437749-25-007519.md) | [39.0](/filings/0001437749-25-016434.md) | [55.0](/filings/0001437749-25-026496.md) | [77.0](/filings/0001437749-25-034818.md) | [46.0 d](/filings/0001437749-26-007965.md) | [78.0](/filings/0001437749-26-015930.md) | [77.0](/filings/0001437749-26-026257.md) | [20.0](/filings/0001437749-25-034818.md) | [55.0 d](/filings/0001437749-26-007965.md) | [77.0](/filings/0001437749-26-015930.md) | [89.0](/filings/0001437749-26-026257.md) |
| Research and development | $k | [5.0](/filings/0001437749-24-032664.md) | [4.0 d](/filings/0001437749-25-007519.md) | [4.0](/filings/0001437749-25-016434.md) | [5.0](/filings/0001437749-25-026496.md) | [6.0](/filings/0001437749-25-034818.md) | [4.0 d](/filings/0001437749-26-007965.md) | [4.0](/filings/0001437749-26-015930.md) | [3.0](/filings/0001437749-26-026257.md) | [4.0](/filings/0001437749-25-034818.md) | [3.0 d](/filings/0001437749-26-007965.md) | [3.0](/filings/0001437749-26-015930.md) | [4.0](/filings/0001437749-26-026257.md) |
| Selling, general and administrative | $k | [746](/filings/0001437749-24-032664.md) | [710 d](/filings/0001437749-25-007519.md) | [763](/filings/0001437749-25-016434.md) | [857](/filings/0001437749-25-026496.md) | [904](/filings/0001437749-25-034818.md) | [987 d](/filings/0001437749-26-007965.md) | [975](/filings/0001437749-26-015930.md) | [926](/filings/0001437749-26-026257.md) | [961](/filings/0001437749-25-034818.md) | [1,095 d](/filings/0001437749-26-007965.md) | [1,212](/filings/0001437749-26-015930.md) | [1,270](/filings/0001437749-26-026257.md) |
| Operating income | $k | [(713)](/filings/0001437749-24-032664.md) | [(625) d](/filings/0001437749-25-007519.md) | [(728)](/filings/0001437749-25-016434.md) | [(807)](/filings/0001437749-25-026496.md) | [(833)](/filings/0001437749-25-034818.md) | [(945) d](/filings/0001437749-26-007965.md) | [(901)](/filings/0001437749-26-015930.md) | [(852)](/filings/0001437749-26-026257.md) | [(945)](/filings/0001437749-25-034818.md) | [(1,043) d](/filings/0001437749-26-007965.md) | [(1,138)](/filings/0001437749-26-015930.md) | [(1,185)](/filings/0001437749-26-026257.md) |
| Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [0.0](/filings/0001437749-24-032664.md) | [0.0 d](/filings/0001437749-25-007519.md) | [0.0](/filings/0001437749-25-016434.md) | [0.0](/filings/0001437749-25-026496.md) | [0.0](/filings/0001437749-25-034818.md) | [0.0 d](/filings/0001437749-26-007965.md) | [0.0](/filings/0001437749-26-015930.md) | [1.0](/filings/0001437749-26-026257.md) | [0.0](/filings/0001437749-25-034818.md) | [0.0 d](/filings/0001437749-26-007965.md) | [0.0](/filings/0001437749-26-015930.md) | [1.0](/filings/0001437749-26-026257.md) |
| Net income | $k | [(466)](/filings/0001437749-24-032664.md) | [(284) d](/filings/0001437749-25-007519.md) | [(314)](/filings/0001437749-25-016434.md) | [(259)](/filings/0001437749-25-026496.md) | [(441)](/filings/0001437749-25-034818.md) | [(496) d](/filings/0001437749-26-007965.md) | [(568)](/filings/0001437749-26-015930.md) | [(524)](/filings/0001437749-26-026257.md) | [(552)](/filings/0001437749-25-034818.md) | [(697) d](/filings/0001437749-26-007965.md) | [(765)](/filings/0001437749-26-015930.md) | [(840)](/filings/0001437749-26-026257.md) |
| Diluted EPS | $ per share | not reported | not reported | [0.00](/filings/0001437749-24-017655.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Basic EPS | $ per share | [0.00](/filings/0001437749-24-032664.md) | not reported | [0.00](/filings/0001437749-25-016434.md) | [0.00](/filings/0001437749-25-026496.md) | [0.00](/filings/0001437749-25-034818.md) | not reported | [0.00](/filings/0001437749-26-015930.md) | [0.00](/filings/0001437749-26-026257.md) | [0.00](/filings/0001437749-25-034818.md) | not reported | [0.00](/filings/0001437749-26-015930.md) | [0.00](/filings/0001437749-26-026257.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [9.7](/filings/0001437749-23-032007.md) | [8.8](/filings/0001437749-25-007519.md) | [9.4](/filings/0001437749-24-017655.md) | [7.4](/filings/0001437749-24-026389.md) | [4.9](/filings/0001437749-24-032664.md) | [6.0](/filings/0001437749-26-007965.md) | [4.9](/filings/0001437749-25-016434.md) | [5.6](/filings/0001437749-25-026496.md) | [8.5](/filings/0001437749-25-034818.md) | [7.2](/filings/0001437749-26-026257.md) | [7.4](/filings/0001437749-26-015930.md) | [8.3](/filings/0001437749-26-026257.md) |
| Current assets | $m | [23.2](/filings/0001437749-23-032007.md) | [22.8](/filings/0001437749-25-007519.md) | [22.3](/filings/0001437749-24-017655.md) | [19.5](/filings/0001437749-24-026389.md) | [17.3](/filings/0001437749-24-032664.md) | [16.1](/filings/0001437749-26-007965.md) | [13.5](/filings/0001437749-25-016434.md) | [14.1](/filings/0001437749-25-026496.md) | [14.9](/filings/0001437749-25-034818.md) | [13.5](/filings/0001437749-26-026257.md) | [14.3](/filings/0001437749-26-015930.md) | [15.3](/filings/0001437749-26-026257.md) |
| Total assets | $m | [32.1](/filings/0001437749-23-032007.md) | [31.8](/filings/0001437749-25-007519.md) | [31.5](/filings/0001437749-24-017655.md) | [31.3](/filings/0001437749-24-026389.md) | [31.1](/filings/0001437749-24-032664.md) | [30.4](/filings/0001437749-26-007965.md) | [30.0](/filings/0001437749-25-016434.md) | [29.6](/filings/0001437749-25-026496.md) | [29.1](/filings/0001437749-25-034818.md) | [29.1](/filings/0001437749-26-026257.md) | [28.6](/filings/0001437749-26-015930.md) | [27.4](/filings/0001437749-26-026257.md) |
| Current liabilities | $m | [0.4](/filings/0001437749-23-032007.md) | [1.2](/filings/0001437749-25-007519.md) | [0.3](/filings/0001437749-24-017655.md) | [1.2](/filings/0001437749-24-026389.md) | [1.3](/filings/0001437749-24-032664.md) | [1.3](/filings/0001437749-26-007965.md) | [1.3](/filings/0001437749-25-016434.md) | [1.4](/filings/0001437749-25-026496.md) | [1.4](/filings/0001437749-25-034818.md) | [1.5](/filings/0001437749-26-026257.md) | [1.8](/filings/0001437749-26-015930.md) | [1.7](/filings/0001437749-26-026257.md) |
| Total liabilities | $m | [1.3](/filings/0001437749-23-032007.md) | [1.2](/filings/0001437749-25-007519.md) | [1.2](/filings/0001437749-24-017655.md) | [1.2](/filings/0001437749-24-026389.md) | [1.3](/filings/0001437749-24-032664.md) | [1.3](/filings/0001437749-26-007965.md) | [1.3](/filings/0001437749-25-016434.md) | [1.4](/filings/0001437749-25-026496.md) | [1.4](/filings/0001437749-25-034818.md) | [2.0](/filings/0001437749-26-026257.md) | [2.2](/filings/0001437749-26-015930.md) | [2.0](/filings/0001437749-26-026257.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [30.7](/filings/0001437749-24-032664.md) | [30.6](/filings/0001437749-26-007965.md) | [30.3](/filings/0001437749-25-026496.md) | [30.1](/filings/0001437749-25-034818.md) | [29.8](/filings/0001437749-25-034818.md) | [29.1](/filings/0001437749-26-026257.md) | [28.6](/filings/0001437749-26-026257.md) | [28.2](/filings/0001437749-26-026257.md) | [27.7](/filings/0001437749-25-034818.md) | [27.1](/filings/0001437749-26-026257.md) | [26.4](/filings/0001437749-26-026257.md) | [25.4](/filings/0001437749-26-026257.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(466) d](/filings/0001437749-24-032664.md) | [(113) d](/filings/0001437749-25-007519.md) | [(196)](/filings/0001437749-25-016434.md) | [53.0 d](/filings/0001437749-25-026496.md) | [8.0 d](/filings/0001437749-25-034818.md) | [(1,022) d](/filings/0001437749-26-007965.md) | [(299)](/filings/0001437749-26-015930.md) | [(280) d](/filings/0001437749-26-026257.md) | [(746) d](/filings/0001437749-25-034818.md) | [(1,427) d](/filings/0001437749-26-007965.md) | [(226)](/filings/0001437749-26-015930.md) | [(193) d](/filings/0001437749-26-026257.md) |
| Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001437749-26-007965.md) | [0.0](/filings/0001437749-26-015930.md) | [0.0 d](/filings/0001437749-26-026257.md) | [3.0 d](/filings/0001437749-25-034818.md) | [1.0 d](/filings/0001437749-26-007965.md) | [315](/filings/0001437749-26-015930.md) | [156 d](/filings/0001437749-26-026257.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2010-06-30) | period not labelled (2010-09-30) | Q2 FY2011 (2011-06-30) | Q3 FY2011 (2011-09-30) | Q1 FY2014 (2014-03-31) | Q2 FY2014 (2014-06-30) | Q3 FY2014 (2014-09-30) | Q1 FY2015 (2015-03-31) | Q2 FY2015 (2015-06-30) | Q3 FY2015 (2015-09-30) | Q1 FY2023 (2023-03-31) | Q1 FY2024 (2024-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [48.5](/filings/0001140361-11-040938.md) | [0.1](/filings/0001140361-11-052953.md) | [181](/filings/0001140361-11-040938.md) | [0.2](/filings/0001140361-11-052953.md) | [388](/filings/0001437749-15-008979.md) | [449](/filings/0001437749-15-015062.md) | [464](/filings/0001437749-15-020244.md) | [464](/filings/0001437749-15-008979.md) | [466](/filings/0001437749-15-015062.md) | [476](/filings/0001437749-15-020244.md) | [917](/filings/0001437749-24-017655.md) | [917](/filings/0001437749-24-017655.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 917,285,149 at 2026-08-06, from the cover of the [10-Q filed 2026-08-06](/filings/0001437749-26-026257.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.